OCT Easier on Infants Than Typical US Method in Determining ROP, Study Says

April 21st 2021, 11:00am


Optical coherence tomography (OCT) appears to be less stressful to preterm infants than ocular indirect ophthalmoscopy (BIO) in assessing retinopathy of prematurity (ROP).

Low Rate of Ocular Abnormalities Seen Among Newborns Exposed to SARS-CoV-2 In Utero

April 19th 2021, 3:00pm


A study of newborns exposed to SARS-CoV-2, the virus that causes COVID-19, during gestation found few instances of ocular abnormalities, with none detected in exposed infants who testing positive.

Optimal Oxygen Saturation to Ward Off ROP Remains Unknown

April 13th 2021, 8:30pm


Higher oxygen saturation targets are linked with greater progression in some cases of retinopathy of prematurity (ROP), but the incidence remains stable.

Evaluating Cost Savings of Adenoviral Conjunctivitis PCR Testing Among Employees

April 9th 2021, 6:30pm


Polymerase chain reaction testing of suspected cases of adenoviral conjunctivitis in a hospital setting resulted in large cost savings by avoiding unnecessary employee furloughs.

Therapy Slows Diabetic Retinopathy but Vision Loss Benefit No Better Than Regular Care

April 7th 2021, 4:00pm


More information will come from 4-year results, which will be critical to assess whether there is any long-term benefit to visual acuity using aflibercept.

Machine Learning Helps Identify Eyes With Pathologic Myopia

March 31st 2021, 4:45pm


Using a support vector machine model, researchers were able to distinguish between eyes with pathologic myopia and healthy myopia.

Formulas May Predict Visual Acuity in Patients With Astigmatism

March 30th 2021, 5:34pm


Researchers developed regression formulas that may be clinically beneficial for estimating visual prognosis after astigmatic correction and determining the surgical indication of astigmatic correction.

Study Finds Higher Rates of Hearing Loss Associated With Teprotumumab

March 23rd 2021, 8:24pm


Study findings presented at ENDO 2021, the Endocrine Society's annual meeting, show rates of hearing loss among 28 patients who took teprotumumab were higher than previously reported in phase 2 and 3 trials.

Comparing Treatment Outcomes in Eyes With Proliferative Diabetic Retinopathy and NVE, NVD

March 22nd 2021, 8:34pm


Disc neovascularization (NVD) was less frequent among patients with proliferative diabetic retinopathy but was associated with more resistance to currently available treatments compared with neovascularization elsewhere (NVE), according to post hoc analysis findings published in JAMA Ophthalmology.

Fear of COVID-19 Limits Patients’ Uptake of Ophthalmic Care

March 16th 2021, 4:45pm


Fear of exposure to COVID-19 is associated with patients missing ophthalmic care appointments, suggesting the potential importance of conveying practices’ infection-control measures, according to results of a non-validated survey.